Clinical Trial

Spartina® (Tirzepatide) Effectiveness and Safety Evaluation

Completed
View on ClinicalTrials.gov →
Summary
The goal of this study is to evaluate Effectiveness and safety of Spartina® (Tirzepatide) in male or female participants with obesity and overweight. The main questions which are aimed to be answered: 1. Is Spartina® (Tirzepatide) effective in the treatment of obesity and overweight? 2. Is Spartina® (Tirzepatide) safe in the treatment of obesity and overweight? In this study, there is no comparison group. Participants receive Spartina® (Tirzepatide)
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-23; most recent amendment 2026-07-14.
Status change: Recruiting → Completed 2026-07-14
Trial Details
NCT Number NCT07262762
Lead Sponsor Cinnagen
Conditions Obesity & Overweight
Enrollment 175 participants
Start Date 2025-11-11
Primary Completion 2026-06-20 (estimated)
Study Completion 2026-07-05 (estimated)
Updated on ClinicalTrials.gov 2026-07-15